NCT01231906-D2
Dataset Information
Dataset ID: NCT01231906-D2
PubMed ID (PMID):
Publication Title:
Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children’s Oncology Group Report
Description of Dataset:
NCT01231906-D2: There are 2 datasets associated with the PMID 34652968: NCT01231906-D1 through NCT01231906-D2. This dataset, NCT01231906-D2, provides the information on adverse events. There are multiple rows per patient one row per patient and adverse event type (AE description).
The contents of this submission reflect the correct data described in the July 15, 2022 erratum (PMID 35839523).
The contents of this submission reflect the correct data described in the July 15, 2022 erratum (PMID 35839523).
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT01231906 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®